Cardinal Health, Inc. $CAH Holdings Increased by Farther Finance Advisors LLC

Key Points

• Farther Finance Advisors increased its Cardinal Health stake by 24.2% in the third quarter to 23,219 shares valued at approximately $4.7 million. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly EPS of $2.91, beating estimates by $0.49, while revenue rose 5.8% year over year to $63.67 billion. The company maintained fiscal 2027 EPS guidance of $12.40–$12.60.
• Analysts remain generally bullish, with a “Moderate Buy” consensus and an average price target of $266.56, compared with a recent share price of $237.33. Cardinal Health also declared a quarterly dividend of $0.5158 per share, yielding about 0.9% annually.

Farther Finance Advisors LLC raised its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 24.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,219 shares of the company's stock after purchasing an additional 4,517 shares during the period. Farther Finance Advisors LLC's holdings in Cardinal Health were worth $4,697,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Cardinal Health in the second quarter worth $6,293,115,000. Wellington Management Group LLP grew its position in Cardinal Health by 247.5% during the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company's stock worth $3,530,206,000 after buying an additional 10,584,119 shares in the last quarter. Bank of America Corp DE purchased a new position in Cardinal Health during the second quarter worth about $689,066,000. Victory Capital Management Inc. increased its stake in Cardinal Health by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,698,189 shares of the company's stock worth $554,478,000 after acquiring an additional 414,074 shares during the last quarter. Finally, Legal & General Group Plc bought a new position in Cardinal Health in the 2nd quarter worth about $438,870,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Down 0.7%

NYSE CAH opened at $237.33 on Friday. The company has a 50-day simple moving average of $233.53 and a two-hundred day simple moving average of $220.87. Cardinal Health, Inc. has a 12-month low of $151.87 and a 12-month high of $258.30. The firm has a market cap of $54.96 billion, a price-to-earnings ratio of 32.83, a PEG ratio of 1.43 and a beta of 0.50.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The firm had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the previous year, the business earned $2.08 earnings per share. The company's quarterly revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities analysts expect that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the sale, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jessica L. Mayer sold 29,436 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the sale, the insider directly owned 33,076 shares of the company's stock, valued at approximately $7,812,220.44. This trade represents a 47.09% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 210,271 shares of company stock worth $49,626,657 over the last quarter. Company insiders own 0.12% of the company's stock.

Wall Street Analysts Forecast Growth

CAH has been the topic of several recent analyst reports. Wells Fargo & Company raised their price target on Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. Morgan Stanley lifted their price target on Cardinal Health from $255.00 to $265.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. JPMorgan Chase & Co. boosted their price objective on Cardinal Health from $215.00 to $260.00 and gave the stock a "neutral" rating in a report on Thursday, August 13th. Royal Bank Of Canada initiated coverage on shares of Cardinal Health in a research report on Wednesday, August 19th. They issued an "outperform" rating and a $276.00 price objective on the stock. Finally, Robert W. Baird raised their target price on shares of Cardinal Health from $251.00 to $274.00 and gave the company an "outperform" rating in a research note on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $266.56.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.